Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation.
about
Regulatory T-cell therapy in transplantation: moving to the clinicTolerance in liver transplantation: Biomarkers and clinical relevanceMarkers of acute rejection and graft acceptance in liver transplantationMHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection.Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppressionThe ratio of circulating regulatory T cells (Tregs)/Th17 cells is associated with acute allograft rejection in liver transplantation.Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsTolerance-inducing strategies in islet transplantationDistinctive Expression of Bcl-2 Factors in Regulatory T Cells Determines a Pharmacological Target to Induce Immunological ToleranceCD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell ProliferationImmune Tolerance for Autoimmune Disease and Cell TransplantationCD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner.Role of T cells in graft rejection and transplantation tolerance.Finding the right time for weaning off immunosuppression in solid organ transplant recipients.Operational tolerance: past lessons and future prospects.Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells.A need for biomarkers of operational tolerance in liver and kidney transplantation.Role of regulatory T cells in the promotion of transplant tolerance.Post-transplant liver biopsy and the immune response: lessons for the clinician.Costimulation blockade: current perspectives and implications for therapy.Signals and pathways controlling regulatory T cells.Islet cell xenotransplantation: a serious look toward the clinicAlloreactive Regulatory T Cells Allow the Generation of Mixed Chimerism and Transplant Tolerance.Regulatory T-cell therapy in liver transplantation.Hot-topic debate on tolerance: immunosuppression withdrawal.Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts.Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated.BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION."Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort.Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match.Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression.A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.Suppressor Properties of Human CD8(+)CD28(-) T Cells in Mixed Leukocyte Reaction are not Affected by CsA and RAPA.Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts
P2860
Q27025869-C2DEFC2B-0FBB-4164-9588-45A22D4F9BACQ28079523-A0067A61-B184-4D70-9129-345A6FB59D9EQ28088272-6E1EE5BA-AB92-43A0-AE3E-C00DD128ED0DQ33685910-552611AD-A40C-437F-847C-ABA045EC2D9BQ34243893-6675A782-7F89-4C08-87B1-249D04446710Q34450497-A4A6D10C-B8EF-4E36-83EF-46EE09101F64Q34459112-FEE7FB59-FD41-42EA-96AA-28F5C2ABC628Q35907218-062B7438-2EA5-4BA2-A0FA-B50A57C4A769Q36004707-B8C93D7E-60AF-467C-A9F6-12A04D32A065Q36632500-0DA66CFF-211A-40B6-B1E6-05E12A2A722AQ36633574-004F5545-15A4-46D6-8C3F-B76149EF42E1Q37099107-4A8A6AD1-503A-476A-A68E-75CFFF6BE4D6Q37274074-E832674D-E85B-49B6-BA09-7C158330E3CEQ37729059-2A139739-6E87-4AC4-8A27-1FA5FB0BFEE9Q37803411-B595B84E-9666-4411-A536-66ECE0BDC6EEQ37850763-86A68755-7673-4732-8229-3AE6FB4F1573Q37864694-9DD9CB5B-93CA-419F-8888-7CC8774B9F6EQ38001063-4A25C855-7F93-4372-B227-DB59F8E5503FQ38004403-4109ED54-CA72-416E-BAA7-526F85D2D90FQ38053173-5C484317-F578-471D-B88A-24E81F2D069BQ38057977-960A8E35-D59C-4541-8704-D6BCA2F541B0Q38187171-842DA178-A6CC-4A5F-8761-2A66799D086CQ38210098-ACF51B04-95E9-4BE4-8420-DDB4BBDC9F06Q38935408-C440D470-94B5-46AD-A1E3-BA8B559C0B02Q39368910-EB253228-91B8-4240-B571-5EB15B973CC4Q39716447-1C1DDA87-0F5B-42BD-83D7-449EFE857DF1Q39957970-95D62C46-4815-40B7-B793-119DDFF6B02FQ40278618-3B67E0E2-0B9E-490A-89FC-6EC3A50231F8Q42234521-CBAEFF76-33F9-4A69-A25D-E6A133DC01B3Q42271695-5757A7C7-9FAF-449F-81A9-C612CAD800D3Q47247195-F5B88213-978C-4612-823B-8DE0F694C276Q50974523-3C28D228-812D-4227-A8B1-2FB39A10DC2AQ52888768-7F35A84C-17F0-47C7-9026-A35A260B0CD4Q53162837-7583AE61-6621-4E0F-921E-9E06EF65924CQ59240791-C3286FE7-5934-4641-982B-507E134AFF8E
P2860
Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Promises and obstacles for the ...... ctions in allotransplantation.
@en
Promises and obstacles for the ...... ctions in allotransplantation.
@nl
type
label
Promises and obstacles for the ...... ctions in allotransplantation.
@en
Promises and obstacles for the ...... ctions in allotransplantation.
@nl
prefLabel
Promises and obstacles for the ...... ctions in allotransplantation.
@en
Promises and obstacles for the ...... ctions in allotransplantation.
@nl
P2093
P1433
P1476
Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation
@en
P2093
Brigitte Le Mauff
Ignacio Anegon
Séverine Ménoret
Xian-Liang Li
P356
10.1097/TP.0B013E31818FEBC4
P577
2008-07-01T00:00:00Z